Leidos Holdings, Inc. (NYSE:LDOS) Shares Purchased by Axecap Investments LLC

Axecap Investments LLC grew its holdings in shares of Leidos Holdings, Inc. (NYSE:LDOS) by 19.6% in the 4th quarter, Holdings Channel reports. The fund owned 28,502 shares of the aerospace company’s stock after buying an additional 4,661 shares during the period. Leidos accounts for 3.1% of Axecap Investments LLC’s investment portfolio, making the stock its 8th largest holding. Axecap Investments LLC’s holdings in Leidos were worth $4,106,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. FMR LLC grew its holdings in shares of Leidos by 27.8% during the third quarter. FMR LLC now owns 2,405,726 shares of the aerospace company’s stock worth $392,133,000 after purchasing an additional 522,764 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in Leidos by 13.1% in the third quarter. JPMorgan Chase & Co. now owns 3,504,392 shares of the aerospace company’s stock valued at $571,216,000 after acquiring an additional 405,256 shares during the last quarter. International Assets Investment Management LLC boosted its holdings in Leidos by 24,194.3% in the third quarter. International Assets Investment Management LLC now owns 377,047 shares of the aerospace company’s stock valued at $61,459,000 after acquiring an additional 375,495 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its holdings in Leidos by 51.2% in the third quarter. Allspring Global Investments Holdings LLC now owns 837,370 shares of the aerospace company’s stock valued at $136,491,000 after acquiring an additional 283,558 shares during the last quarter. Finally, Barclays PLC boosted its holdings in Leidos by 53.1% in the third quarter. Barclays PLC now owns 576,022 shares of the aerospace company’s stock valued at $93,891,000 after acquiring an additional 199,686 shares during the last quarter. Institutional investors and hedge funds own 76.12% of the company’s stock.

Insider Transactions at Leidos

In related news, Director Noel B. Geer bought 2,000 shares of the business’s stock in a transaction on Wednesday, November 20th. The stock was acquired at an average price of $161.13 per share, for a total transaction of $322,260.00. Following the purchase, the director now directly owns 2,000 shares in the company, valued at $322,260. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.96% of the stock is owned by corporate insiders.

Leidos Stock Up 0.4 %

Shares of NYSE:LDOS opened at $142.86 on Tuesday. The company has a market capitalization of $19.06 billion, a PE ratio of 16.27, a price-to-earnings-growth ratio of 0.92 and a beta of 0.66. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.23 and a quick ratio of 1.15. The business has a fifty day moving average price of $149.74 and a two-hundred day moving average price of $157.78. Leidos Holdings, Inc. has a 1 year low of $113.67 and a 1 year high of $202.90.

Leidos Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, March 28th. Stockholders of record on Friday, March 14th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.60 annualized dividend and a dividend yield of 1.12%. Leidos’s payout ratio is 18.22%.

Wall Street Analyst Weigh In

LDOS has been the topic of several analyst reports. UBS Group initiated coverage on Leidos in a report on Monday, December 2nd. They issued a “neutral” rating and a $182.00 target price on the stock. Wells Fargo & Company cut their price target on Leidos from $205.00 to $199.00 and set an “overweight” rating on the stock in a report on Wednesday, January 8th. Truist Financial cut their price target on Leidos from $205.00 to $185.00 and set a “buy” rating on the stock in a report on Friday, November 22nd. The Goldman Sachs Group lowered Leidos from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $228.00 to $153.00 in a research report on Thursday, December 12th. Finally, Barclays upped their target price on Leidos from $165.00 to $210.00 and gave the stock an “overweight” rating in a research report on Monday, November 4th. Five research analysts have rated the stock with a hold rating, nine have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $179.47.

Leidos Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.